Skip to main content

Articles

Page 38 of 59

  1. Both uremia and metabolic syndrome (MetS) affect heart rate variability (HRV) which is a risk factor of poor prognoses. The aim of this study was to evaluate the impact of MetS on HRV among chronic hemodialysi...

    Authors: Yu-Ming Chang, Chih-Chung Shiao, Ya-Ting Huang, I-Ling Chen, Chuan-Lan Yang, Show-Chin Leu, Hung-Li Su, Jsun-Liang Kao, Shih-Ching Tsai, Rong-Na Jhen and Ching-Cherng Uen
    Citation: Cardiovascular Diabetology 2016 15:16

    The Erratum to this article has been published in Cardiovascular Diabetology 2017 16:90

  2. Older patients with longstanding type 1 diabetes have high cardiovascular disease (CVD) risk such that statin therapy is recommended independent of prior CVD events. We aimed to determine self-reported CVD pr...

    Authors: Johnny W. Bai, Geneviève Boulet, Elise M. Halpern, Leif E. Lovblom, Devrim Eldelekli, Hillary A. Keenan, Michael Brent, Narinder Paul, Vera Bril, David Z. I. Cherney, Alanna Weisman and Bruce A. Perkins
    Citation: Cardiovascular Diabetology 2016 15:14
  3. Carotid intima-media thickness (cIMT) holds prognostic information for future cardiovascular disease and is associated with the extent of coronary atherosclerosis. We investigated the effect of exercise on cIM...

    Authors: Rune Byrkjeland, Knut-Haakon Stensæth, Sigmund Anderssen, Ida U. Njerve, Harald Arnesen, Ingebjørg Seljeflot and Svein Solheim
    Citation: Cardiovascular Diabetology 2016 15:13
  4. Lipoprotein-related mechanisms have been associated with damage to the cardiovascular system in diabetic patients. Apolipoprotein E gene which affects the clearance of lipoproteins and consequently the lipid p...

    Authors: Dalia El-Lebedy, Hala M. Raslan and Asmaa M. Mohammed
    Citation: Cardiovascular Diabetology 2016 15:12

    The Erratum to this article has been published in Cardiovascular Diabetology 2016 15:35

  5. Recent data support the renewed interest in hypertriglyceridemia as a possible important therapeutic target for cardiovascular risk reduction. This study was designed to address the question of all-cause morta...

    Authors: Yaron Arbel, Robert Klempfner, Aharon Erez, Ilan Goldenberg, Sagit Benzekry, Nir Shlomo, Enrique Z. Fisman and Alexander Tenenbaum
    Citation: Cardiovascular Diabetology 2016 15:11
  6. We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes.

    Authors: Ryotaro Bouchi, Norihiko Ohara, Masahiro Asakawa, Yujiro Nakano, Takato Takeuchi, Masanori Murakami, Yuriko Sasahara, Mitsuyuki Numasawa, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto and Yoshihiro Ogawa
    Citation: Cardiovascular Diabetology 2016 15:10
  7. The aims of this study were to investigate whether circulating irisin is associated with favorable metabolic parameters and how the association differs according to body composition in humans.

    Authors: You-Cheol Hwang, Won Seon Jeon, Cheol-Young Park and Byung-Soo Youn
    Citation: Cardiovascular Diabetology 2016 15:9
  8. Hypertension is a multi-factorial disease of increasing prevalence and a major risk factor for cardiovascular mortality even in the presence of adequate treatment. Progression of cardiovascular disease (CVD) o...

    Authors: Laura Gonzalez-Calero, Marta Martin-Lorenzo, Fernando de la Cuesta, Aroa S. Maroto, Montserrat Baldan-Martin, Gema Ruiz-Hurtado, Helena Pulido-Olmo, Julian Segura, Maria G. Barderas, Luis M. Ruilope, Fernando Vivanco and Gloria Alvarez-Llamas
    Citation: Cardiovascular Diabetology 2016 15:8
  9. The prevention of cardiovascular disease, including diastolic cardiac dysfunction with its high prevalence and ominous prognosis, is a therapeutic challenge for patients with type 2 diabetes. Both short and lo...

    Authors: Helene von Bibra, Thorsten Siegmund, Iris Kingreen, Markus Riemer, Tibor Schuster and Petra-Maria Schumm-Draeger
    Citation: Cardiovascular Diabetology 2016 15:7
  10. Platelet hyper-reactivity is a crucial cause of accelerated atherosclerosis increasing risk of thrombotic vascular events in diabetic patients. The mechanisms leading to abnormal platelet activity during diab...

    Authors: Wenqing Wang, Wayne Bond Lau, Yajing Wang, Xinliang Ma and Rong Li
    Citation: Cardiovascular Diabetology 2016 15:6
  11. We evaluated the risks of renal and cardiovascular complications, and mortality associated with lower extremity amputation (LEA) in patients with type 1 diabetes.

    Authors: Kamel Mohammedi, Louis Potier, Narimène Belhatem, Nadia Matallah, Samy Hadjadj, Ronan Roussel, Michel Marre and Gilberto Velho
    Citation: Cardiovascular Diabetology 2016 15:5
  12. Circadian rhythms regulate key biological processes influencing metabolic pathways. Disregulation is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). Circadian rhythms are generated by...

    Authors: Dolores Corella, Eva. M. Asensio, Oscar Coltell, José V. Sorlí, Ramón Estruch, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Olga Castañer, Fernando Arós, José Lapetra, Lluís Serra-Majem, Enrique Gómez-Gracia, Carolina Ortega-Azorín, Miquel Fiol, Javier Díez Espino, Andrés Díaz-López…
    Citation: Cardiovascular Diabetology 2016 15:4
  13. Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development...

    Authors: Chang-Chiang Chen, Hendra Susanto, Wen-Han Chuang, Ta-Yu Liu and Chih-Hong Wang
    Citation: Cardiovascular Diabetology 2016 15:3

    The Erratum to this article has been published in Cardiovascular Diabetology 2017 16:58

  14. Data regarding the long-term clinical outcomes in patients with insulin-treated type 2 diabetes mellitus (ITDM) revascularized by either coronary artery bypass surgery (CABG) or percutaneous coronary intervent...

    Authors: Pravesh Kumar Bundhun, Zi Jia Wu and Meng-Hua Chen
    Citation: Cardiovascular Diabetology 2016 15:2
  15. Previous studies have shown that angiopoietin-like protein 8 (ANGPTL8), also called as betatrophin, acts together with ANGPTL3 to regulate lipid metabolism, glucose metabolism, and energy homeostasis. Moreover...

    Authors: Hye Soo Chung, Min Jung Lee, Soon Young Hwang, Hyun Jung Lee, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Seon Mi Kim and Kyung Mook Choi
    Citation: Cardiovascular Diabetology 2016 15:1
  16. To investigate the long-term efficacy and safety of empagliflozin monotherapy compared with placebo and sitagliptin in drug-naïve patients with type 2 diabetes mellitus.

    Authors: Michael Roden, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans J. Woerle and Uli C. Broedl
    Citation: Cardiovascular Diabetology 2015 14:154
  17. States of hyperinsulinemia, particularly insulin resistance and type 2 diabetes mellitus, are becoming remarkably common, with roughly half a billion people likely to suffer from the disorder within the next 1...

    Authors: Aimee E. Hodson, Trevor S. Tippetts and Benjamin T. Bikman
    Citation: Cardiovascular Diabetology 2015 14:153
  18. To determine temporal changes in the prevalence and associates of lower extremity amputation (LEA) complicating type 2 diabetes.

    Authors: Mendel Baba, Wendy A. Davis, Paul E. Norman and Timothy M. E. Davis
    Citation: Cardiovascular Diabetology 2015 14:152
  19. Remote ischemic perconditioning (RIPerC) has a promising therapeutic insight to improve the prognosis of acute myocardial infarction. Chronic comorbidities such as diabetes are known to interfere with conditio...

    Authors: Tamás Baranyai, Csilla Terézia Nagy, Gábor Koncsos, Zsófia Onódi, Melinda Károlyi-Szabó, András Makkos, Zoltán V. Varga, Péter Ferdinandy and Zoltán Giricz
    Citation: Cardiovascular Diabetology 2015 14:151
  20. It remains to be established if, and to what extent, the coronary microcirculation becomes compromised during the development of obesity and insulin resistance. Recent studies suggest that changes in endotheli...

    Authors: Judith van Haare, M. Eline Kooi, Hans Vink, Mark J. Post, Jurgen W. G. E. van Teeffelen, Jos Slenter, Chantal Munts, Hanneke Cobelens, Gustav J. Strijkers, Dennis Koehn and Marc van Bilsen
    Citation: Cardiovascular Diabetology 2015 14:150

    The Correction to this article has been published in Cardiovascular Diabetology 2021 20:51

  21. The effects of streptozotocin (STZ)-induced diabetes on heart metabolism and function after myocardial infarction (MI) remodelling were investigated in rats.

    Authors: Christiane Malfitano, Alcione Lescano de Souza Junior, Mariana Carbonaro, Andressa Bolsoni-Lopes, Diego Figueroa, Leandro Ezequiel de Souza, Kleiton Augusto Santos Silva, Fernanda Consolim-Colombo, Rui Curi and Maria Claudia Irigoyen
    Citation: Cardiovascular Diabetology 2015 14:149
  22. The heart requires constant sources of energy mostly from free fatty acids (FFA) and glucose. The alteration in myocardial substrate metabolism occurs in the heart of diabetic patients, but its specific associ...

    Authors: Gyuri Kim, Kwanhyeong Jo, Kwang Joon Kim, Yong-ho Lee, Eugene Han, Hye-jin Yoon, Hye Jin Wang, Eun Seok Kang and Mijin Yun
    Citation: Cardiovascular Diabetology 2015 14:148
  23. Few studies have investigated the association between coronary artery calcium (CAC) progression and arterial stiffness measured by brachial-ankle pulse wave velocity (baPWV). We examined the influence of the s...

    Authors: Jong-Young Lee, Seungho Ryu, Sung Ho Lee, Byung Jin Kim, Bum-Soo Kim, Jin-Ho Kang, Eun Sun Cheong, Jang-Young Kim, Jeong Bae Park and Ki-Chul Sung
    Citation: Cardiovascular Diabetology 2015 14:147
  24. Type 2 diabetes mellitus is an important risk factor in the development of coronary artery disease (CAD) and is often associated with severe disease. However, this risk is not uniform, some patients remain fre...

    Authors: Mukund P. Srinivasan, Padmanabh K. Kamath, Narayan M. Bhat, Narasimha D. Pai, Poornima A. Manjrekar and Chakrapani Mahabala
    Citation: Cardiovascular Diabetology 2015 14:146
  25. Diabetes mellitus (DM) leads to the development of diabetic cardiomyopathy, which is associated with altered nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) signalling. ...

    Authors: Csaba Mátyás, Balázs Tamás Németh, Attila Oláh, László Hidi, Ede Birtalan, Dalma Kellermayer, Mihály Ruppert, Sevil Korkmaz-Icöz, Gábor Kökény, Eszter Mária Horváth, Gábor Szabó, Béla Merkely and Tamás Radovits
    Citation: Cardiovascular Diabetology 2015 14:145
  26. We aimed to determine the association between nonalcoholic fatty liver disease (NAFLD) and diabetes risk among body size phenotypes which was based on cross-classification of body mass index (BMI) categories (...

    Authors: Tingting Du, Xuefeng Yu, Gang Yuan, Jianhua Zhang and Xingxing Sun
    Citation: Cardiovascular Diabetology 2015 14:144
  27. Diabetic patients are more sensitive to myocardial ischemic injury than non-diabetic patients. Silent information regulator 1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent histone deacetylase making...

    Authors: Mingge Ding, Jingyi Lei, Hongcheng Han, Weibo Li, Yinxian Qu, Enqing Fu, Feng Fu and Xiaoming Wang
    Citation: Cardiovascular Diabetology 2015 14:143
  28. Although antidiabetic agents have been developed to target one or more of the core defects of type 2 diabetes mellitus (T2DM), many patients do not achieve glycemic goals. Inhibition of the sodium-glucose cotr...

    Authors: Paola Fioretto, Andrea Giaccari and Giorgio Sesti
    Citation: Cardiovascular Diabetology 2015 14:142
  29. After acute myocardial infarction (AMI), the replicated phenomenon of obesity paradox, i.e., obesity appearing to be associated with increased survival, has not been evaluated in stabilized (i.e., without clin...

    Authors: Ki-Bum Won, Seung-Ho Hur, Yun-Kyeong Cho, Hyuck-Jun Yoon, Chang-Wook Nam, Kwon-Bae Kim, Jang-Ho Bae, Dong-Ju Choi, Young-Keun Ahn, Jong-Seon Park, Hyo-Soo Kim, Rak-Kyeong Choi, Donghoon Choi, Joon-Hong Kim, Kyoo-Rok Han, Hun-Sik Park…
    Citation: Cardiovascular Diabetology 2015 14:141

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:159

  30. Whereas a few studies have reported associations of serum omentin levels with subclinical atherosclerosis in patients with diabetes, little information is available with respect to the associations of serum om...

    Authors: Chan-Hee Jung, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang and Ji-Oh Mok
    Citation: Cardiovascular Diabetology 2015 14:140
  31. The object of this study was to investigate the potential role of FGF23 on plaque stability in type 2 diabetic patients with internal carotid artery stenosis.

    Authors: Federico Biscetti, Giuseppe Straface, Carlo Filippo Porreca, Giovanni Bertoletti, Claudio Vincenzoni, Francesco Snider, Egidio Stigliano, Vincenzo Arena, Flavia Angelini, Giovanni Pecorini, Antonio Bianchi, Raffaele Landolfi and Andrea Flex
    Citation: Cardiovascular Diabetology 2015 14:139
  32. Many factors influence whether the first-line oral anti-diabetic drug, metformin, should be initiated to a patient with type 2 diabetes mellitus (T2DM) early in the course of management in addition to lifestyl...

    Authors: Colman Siu Cheung Fung, Eric Yuk Fai Wan, Carlos King Ho Wong, Fangfang Jiao and Anca Ka Chun Chan
    Citation: Cardiovascular Diabetology 2015 14:137
  33. Abdominal visceral obesity has been reported to be associated with cardiovascular risks than body mass index, waist circumference, and abdominal subcutaneous fat. On the other hand, there is evidence that subc...

    Authors: Ryotaro Bouchi, Takato Takeuchi, Momoko Akihisa, Norihiko Ohara, Yujiro Nakano, Rie Nishitani, Masanori Murakami, Tatsuya Fukuda, Masamichi Fujita, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto and Yoshihiro Ogawa
    Citation: Cardiovascular Diabetology 2015 14:136
  34. Type 2 diabetes mellitus (DM) patients have worse adverse cardiovascular outcomes after Percutaneous Coronary Intervention (PCI). However, the adverse cardiovascular outcomes between insulin-treated and non-in...

    Authors: Pravesh Kumar Bundhun, Nuo Li and Meng-Hua Chen
    Citation: Cardiovascular Diabetology 2015 14:135
  35. Diabetic cardiomyopathy (DCM), a fatal cardiovascular complication of diabetes mellitus, often leads to progressive heart failure, however its pathogenesis remains unclear. Corin, a cardiac serine protease, is...

    Authors: Aiming Pang, Yahui Hu, Pengfei Zhou, Guangfeng Long, Xin Tian, Li Men, Yanna Shen, Yunde Liu and Yujie Cui
    Citation: Cardiovascular Diabetology 2015 14:134
  36. In order to influence every day clinical practice professional organisations issue management guidelines. Cross-sectional surveys are used to evaluate the implementation of such guidelines. The present survey ...

    Authors: Viveca Gyberg, Dirk De Bacquer, Guy De Backer, Catriona Jennings, Kornelia Kotseva, Linda Mellbin, Oliver Schnell, Jaakko Tuomilehto, David Wood, Lars Rydén, Philippe Amouyel, Jan Bruthans, Almudena Castro Conde, Renata Cifkova, Jaap W. Deckers, Johan De Sutter…
    Citation: Cardiovascular Diabetology 2015 14:133
  37. The purpose of this study was to analyze the evolution of vascular, cardiac and renal target organ damage (TOD) in patients with increased insulin resistance over a 3.5 year follow-up and to investigate gender...

    Authors: Manuel Ángel Gómez-Marcos, José Ignacio Recio-Rodríguez, Leticia Gómez-Sánchez, Cristina Agudo-Conde, Emiliano Rodríguez-Sanchez, JoseAngel Maderuelo-Fernandez, Marta Gomez-Sanchez and Luís García-Ortiz
    Citation: Cardiovascular Diabetology 2015 14:132
  38. Diabetes mellitus (DM) and aortic stenosis (AS) are frequent findings in the elderly population. Data regarding the influence of DM on the outcomes of patients undergoing transcatheter aortic valve replacemen...

    Authors: Anat Berkovitch, Amit Segev, Israel Barbash, Yoni Grossman, Elad Maor, Aharon Erez, Ehud Regev, Noam Fink, Israel Mazin, Ashraf Hamdan, Ilan Goldenberg, Ilan Hay, Dan Spiegelstien, Victor Guetta and Paul Fefer
    Citation: Cardiovascular Diabetology 2015 14:131
  39. Increased cardiac fat has been identified as a risk factor for coronary artery disease. Metabolic syndrome is associated with increased cardiac fat deposition. Steroids are known to imitate some effects of met...

    Authors: Daniel Kitterer, Joerg Latus, Joerg Henes, Stefan Birkmeier, Maik Backes, Niko Braun, Udo Sechtem, M. Dominik Alscher, Heiko Mahrholdt and Simon Greulich
    Citation: Cardiovascular Diabetology 2015 14:130
  40. Authors: Stijn A Peeters, Lian Engelen, Jacqueline Buijs, Nish Chaturvedi, John H Fuller, Casper G Schalkwijk and Coen D Stehouwer
    Citation: Cardiovascular Diabetology 2015 14:128

    The original article was published in Cardiovascular Diabetology 2015 14:31

  41. Cardiomyopathy is a devastating complication of obesity and type 2 diabetes mellitus (T2DM). It arises even in patients with normoglycemia (glycosylated hemoglobin, A1C ≤7 %). As obesity and T2DM are approachi...

    Authors: Nathan W. Roberts, Magdalis González-Vega, Tirsit K. Berhanu, Aaron Mull, Jesús García and Ahlke Heydemann
    Citation: Cardiovascular Diabetology 2015 14:127
  42. Advanced glycation end products (AGEs) play a role in the development of late complications and atherosclerosis in diabetes by engaging the receptor for advanced glycation end products, RAGE. Receptor binding ...

    Authors: Martin Heier, Hanna Dis Margeirsdottir, Mario Gaarder, Knut Haakon Stensæth, Cathrine Brunborg, Peter Abusdal Torjesen, Ingebjørg Seljeflot, Kristian Folkvord Hanssen and Knut Dahl-Jørgensen
    Citation: Cardiovascular Diabetology 2015 14:126
  43. IL-1β was considered as an important inflammatory cytokine in diabetic cardiovascular complications. DCM is one of the major manifestations of diabetic cardiovascular complications whose specific mechanisms ar...

    Authors: Zhongwei Liu, Na Zhao, Huolan Zhu, Shunming Zhu, Shuo Pan, Jing Xu, Xuejun Zhang, Yong Zhang and Junkui Wang
    Citation: Cardiovascular Diabetology 2015 14:125
  44. Whether lowering glycosylated haemoglobin (HbA1c) level below 7.0 % improves macro-vascular outcomes in diabetes remains unclear. Here, we aimed to assess the effect of relatively tight glucose control resulti...

    Authors: Pin Wang, Rong Huang, Sen Lu, Wenqing Xia, Haixia Sun, Jie Sun, Rongrong Cai and Shaohua Wang
    Citation: Cardiovascular Diabetology 2015 14:124
  45. Type 2 diabetes mellitus (T2DM) complicated by retinopathy is associated with altered left ventricular (LV) structure and resting myocardial dysfunction unlike T2DM without retinopathy. The myocardial response...

    Authors: Zhe Zhen, Yan Chen, Kendrick Shih, Ju-Hua Liu, Michele Yuen, David Sai-Hung Wong, Karen Siu-Ling Lam, Hung-Fat Tse and Kai-Hang Yiu
    Citation: Cardiovascular Diabetology 2015 14:123
  46. Whole body cardiovascular MR (WB CVMR) combines whole body angiography and cardiac MR assessment. It is accepted that there is a high disease burden in patients with diabetes, however the quantification of the...

    Authors: Suzanne L. Duce, Jonathan R. Weir-McCall, Stephen J. Gandy, Shona Z. Matthew, Deirdre B. Cassidy, Lynne McCormick, Petra Rauchhaus, Helen Looker, Helen M. Colhoun and J. Graeme Houston
    Citation: Cardiovascular Diabetology 2015 14:122
  47. The glycoprotein YKL-40 is a new marker of early inflammation and endothelial dysfunction. Adiponectin is a collagen-like protein with anti-atherogenic and anti-inflammatory effects. Increased concentrations o...

    Authors: Eva Aguilera, Enric Serra-Planas, M. Luisa Granada, Silvia Pellitero, Jordi L. Reverter, Núria Alonso, Berta Soldevila, Dídac Mauricio and Manel Puig-Domingo
    Citation: Cardiovascular Diabetology 2015 14:121
  48. Diabetes and impaired glucose tolerance (IGT) are major risk factors for atherosclerosis including coronary artery disease (CAD). The present study’s aim was to investigate the importance of glucose tolerance ...

    Authors: Jeanette Kuhl, Gun Jörneskog, Malin Wemminger, Mattias Bengtsson, Pia Lundman and Majid Kalani
    Citation: Cardiovascular Diabetology 2015 14:120

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions